2015-2025 Global Nonalcoholic Steatohepatitis (NASH) Market Research by Type, End-Use and Region

July 2020 | 121 pages | ID: 2DCF533FB183EN
99Strategy

Abstracts

SUMMARY


The global Nonalcoholic Steatohepatitis (NASH) market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Boehringer Ingelheim
• Cerenis Therapeutics
• Connexios Life Sciences
• Genfit
• Islet Sciences
• Nimbus Therapeutics
• Verva Pharmaceuticals
• Viking Therapeutics
• Astazeneca Plc
• Galmed Pharmaceuticals
• GENFIT SA
• Gilead Science
• Novo Nordisk
• Immuron
• Intercepts Pharmaceuticals
• Enzo Biochem
• Tobira Therapeutics

Key Types

• Weight Loss Treatment
• Insulin-Sensitizing Agents
• Lipid-Lowering Drugs
• Antioxidants
• Others

Key End-Use

• Hospitals
• Clinics
• Research Institute
• Others

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaNonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Table Europe Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Table America Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Figure America Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Table Asia Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Table Africa Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Nonalcoholic Steatohepatitis (NASH) Production Forecast
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Type
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2020E-2025F (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2025 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2020E-2025F (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2025 (Volume)
8.3 Global Nonalcoholic Steatohepatitis (NASH) Forecast by End-Use (2020E-2025F)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2020E-2025F)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by Region in 2025 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Boehringer Ingelheim
  9.1.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
  9.1.2 Boehringer Ingelheim Products & Services
  9.1.3 Boehringer Ingelheim Company Dynamics & News
  9.1.4 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Cerenis Therapeutics
  9.2.1 Cerenis Therapeutics Profile
Table Cerenis Therapeutics Overview List
  9.2.2 Cerenis Therapeutics Products & Services
  9.2.3 Cerenis Therapeutics Company Dynamics & News
  9.2.4 Cerenis Therapeutics Business Operation Conditions
Table Business Operation of Cerenis Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Connexios Life Sciences
  9.3.1 Connexios Life Sciences Profile
Table Connexios Life Sciences Overview List
  9.3.2 Connexios Life Sciences Products & Services
  9.3.3 Connexios Life Sciences Company Dynamics & News
  9.3.4 Connexios Life Sciences Business Operation Conditions
Table Business Operation of Connexios Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Genfit
  9.4.1 Genfit Profile
Table Genfit Overview List
  9.4.2 Genfit Products & Services
  9.4.3 Genfit Company Dynamics & News
  9.4.4 Genfit Business Operation Conditions
Table Business Operation of Genfit (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Islet Sciences
  9.5.1 Islet Sciences Profile
Table Islet Sciences Overview List
  9.5.2 Islet Sciences Products & Services
  9.5.3 Islet Sciences Company Dynamics & News
  9.5.4 Islet Sciences Business Operation Conditions
Table Business Operation of Islet Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Nimbus Therapeutics
  9.6.1 Nimbus Therapeutics Profile
Table Nimbus Therapeutics Overview List
  9.6.2 Nimbus Therapeutics Products & Services
  9.6.3 Nimbus Therapeutics Company Dynamics & News
  9.6.4 Nimbus Therapeutics Business Operation Conditions
Table Business Operation of Nimbus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Verva Pharmaceuticals
  9.7.1 Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Overview List
  9.7.2 Verva Pharmaceuticals Products & Services
  9.7.3 Verva Pharmaceuticals Company Dynamics & News
  9.7.4 Verva Pharmaceuticals Business Operation Conditions
Table Business Operation of Verva Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Viking Therapeutics
  9.8.1 Viking Therapeutics Profile
Table Viking Therapeutics Overview List
  9.8.2 Viking Therapeutics Products & Services
  9.8.3 Viking Therapeutics Company Dynamics & News
  9.8.4 Viking Therapeutics Business Operation Conditions
Table Business Operation of Viking Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Astazeneca Plc
  9.9.1 Astazeneca Plc Profile
Table Astazeneca Plc Overview List
  9.9.2 Astazeneca Plc Products & Services
  9.9.3 Astazeneca Plc Company Dynamics & News
  9.9.4 Astazeneca Plc Business Operation Conditions
Table Business Operation of Astazeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Galmed Pharmaceuticals
  9.10.1 Galmed Pharmaceuticals Profile
Table Galmed Pharmaceuticals Overview List
  9.10.2 Galmed Pharmaceuticals Products & Services
  9.10.3 Galmed Pharmaceuticals Company Dynamics & News
  9.10.4 Galmed Pharmaceuticals Business Operation Conditions
Table Business Operation of Galmed Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 GENFIT SA
  9.11.1 GENFIT SA Profile
Table GENFIT SA Overview List
  9.11.2 GENFIT SA Products & Services
  9.11.3 GENFIT SA Company Dynamics & News
  9.11.4 GENFIT SA Business Operation Conditions
Table Business Operation of GENFIT SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Gilead Science
  9.12.1 Gilead Science Profile
Table Gilead Science Overview List
  9.12.2 Gilead Science Products & Services
  9.12.3 Gilead Science Company Dynamics & News
  9.12.4 Gilead Science Business Operation Conditions
Table Business Operation of Gilead Science (Sales Revenue, Cost, Gross Margin)
9.13 Novo Nordisk
  9.13.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
  9.13.2 Novo Nordisk Products & Services
  9.13.3 Novo Nordisk Company Dynamics & News
  9.13.4 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Immuron
  9.14.1 Immuron Profile
Table Immuron Overview List
  9.14.2 Immuron Products & Services
  9.14.3 Immuron Company Dynamics & News
  9.14.4 Immuron Business Operation Conditions
Table Business Operation of Immuron (Sales Revenue, Cost, Gross Margin)
9.15 Intercepts Pharmaceuticals
  9.15.1 Intercepts Pharmaceuticals Profile
Table Intercepts Pharmaceuticals Overview List
  9.15.2 Intercepts Pharmaceuticals Products & Services
  9.15.3 Intercepts Pharmaceuticals Company Dynamics & News
  9.15.4 Intercepts Pharmaceuticals Business Operation Conditions
Table Business Operation of Intercepts Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.16 Enzo Biochem
  9.16.1 Enzo Biochem Profile
Table Enzo Biochem Overview List
  9.16.2 Enzo Biochem Products & Services
  9.16.3 Enzo Biochem Company Dynamics & News
  9.16.4 Enzo Biochem Business Operation Conditions
Table Business Operation of Enzo Biochem (Sales Revenue, Cost, Gross Margin)
9.17 Tobira Therapeutics
  9.17.1 Tobira Therapeutics Profile
Table Tobira Therapeutics Overview List
  9.17.2 Tobira Therapeutics Products & Services
  9.17.3 Tobira Therapeutics Company Dynamics & News
  9.17.4 Tobira Therapeutics Business Operation Conditions
Table Business Operation of Tobira Therapeutics (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume by Companies, 2015-2020E (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio in 2020E
Figure America Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio in 2020E
Figure Asia Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio in 2020E
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio in 2020E
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON NONALCOHOLIC STEATOHEPATITIS (NASH) INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 NONALCOHOLIC STEATOHEPATITIS (NASH) INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Table Europe Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)
Table America Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Table America Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table America Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Table Asia Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Nonalcoholic Steatohepatitis (NASH) Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2015-2020 (Million USD)
Table Africa Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2015-2020 (Volume)
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2015-2020 (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Type, 2020E-2025F (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Production Volume by Type, 2020E-2025F (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume by Region, 2020E-2025F (Volume)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cerenis Therapeutics Overview List
Table Business Operation of Cerenis Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Connexios Life Sciences Overview List
Table Business Operation of Connexios Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genfit Overview List
Table Business Operation of Genfit (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Islet Sciences Overview List
Table Business Operation of Islet Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nimbus Therapeutics Overview List
Table Business Operation of Nimbus Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Verva Pharmaceuticals Overview List
Table Business Operation of Verva Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Viking Therapeutics Overview List
Table Business Operation of Viking Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astazeneca Plc Overview List
Table Business Operation of Astazeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galmed Pharmaceuticals Overview List
Table Business Operation of Galmed Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GENFIT SA Overview List
Table Business Operation of GENFIT SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Science Overview List
Table Business Operation of Gilead Science (Sales Revenue, Cost, Gross Margin)
Table Novo Nordisk Overview List
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immuron Overview List
Table Business Operation of Immuron (Sales Revenue, Cost, Gross Margin)
Table Intercepts Pharmaceuticals Overview List
Table Business Operation of Intercepts Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Enzo Biochem Overview List
Table Business Operation of Enzo Biochem (Sales Revenue, Cost, Gross Margin)
Table Tobira Therapeutics Overview List
Table Business Operation of Tobira Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume by Companies, 2015-2020E (Volume)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaNonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
Figure America Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2020 (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2020 (Volume)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type in 2025 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Production Volume Share by Type in 2025 (Volume)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Value Share by Region in 2025 (Million USD)
Figure Global Nonalcoholic Steatohepatitis (NASH) Consumption Volume Share by Region in 2025 (Volume)